Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.
| Revenue (TTM) | $351.50M |
| Gross Profit (TTM) | $155.76M |
| EBITDA | $-8.81M |
| Operating Margin | -9.89% |
| Return on Equity | -13.10% |
| Return on Assets | -6.14% |
| Revenue/Share (TTM) | $12.95 |
| Book Value | $6.68 |
| Price-to-Book | 0.95 |
| Price-to-Sales (TTM) | 0.49 |
| EV/Revenue | 0.228 |
| EV/EBITDA | -17.60 |
| Quarterly Earnings Growth (YoY) | 87.30% |
| Quarterly Revenue Growth (YoY) | 3.40% |
| Shares Outstanding | $27.07M |
| Float | $23.85M |
| % Insiders | 11.90% |
| % Institutions | 77.77% |
Volatility is currently expanding